MAZE: Maze Tx P/S multiplikatori

Maze Therapeutics Corp (MAZE) tovar belgisi

Maze Therapeutics Inc (MAZE) rivojlanishi Pompe kasalligi davolashidagi yutuqlarga va Sanofi bilan hamkorligiga tayanadi. Daromad koeffitsiyenti genom tahrirlashdagi intellektual monopoliyaning aktiv qiymatini qanday shakllantirishini ko'rsatadi, bunda 97.10 belgisi joriy baholash darajasini anglatadi. Biroq, sotuvlarning yo'qligi va naqd pullarning jadal sarflanishi investorlar uchun jiddiy moliyaviy xatarlarni yuzaga keltirmoqda.

Maze Tx (MAZE) - P/S multiplikatori 14.08.2025dan 16.11.2026gacha

Maze Tx (MAZE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:MAZE, Maze Therapeutics
Maze Therapeutics, Inc. brend mahsuloti

Maze Therapeutics Inc (MAZE) kompaniyasida operatsion risklar va kapital rentabelligi o'rtasidagi muvozanatni topish bozor qiymatini haqiqiy savdo hajmi bilan solishtirishni talab qiladi. P/S tebranishlarini tahlil qilish orqali investor aniq genetika va AI modellashtiruvi uchun innovatsion premiumni baholaydi, bu esa joriy kapitalizatsiyaning qanchalik darajada ilmiy va texnologik salohiyat hamda uzoq muddatli biznes barqarorligi bilan asoslanganligini belgilaydi.

Raqobatdosh kompaniyalar

TEM (Tempus AI, Inc.) - Bozor kapitallashuvining daromadga nisbati|Qiagen Group - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati IONS|RGEN - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Avidity Biosciences RNA|CRSP: P/S multiplikatori|Kapitalizatsiya va daromad nisbati WGS|RARE (Ultragenyx Pharma) - P/S multiplikatori|P/S multiplikatori Beam Therapeutics Inc.|Narxning daromadga nisbati Sarepta Therapeutics Inc (SRPT)|Twist Bioscience - Kapitalizatsiya va daromad nisbati|10x Genomics Inc - Kapitalizatsiyaning daromadga nisbati|NTLA (Intellia Therapeutics, Inc.) - Narxning sotuvga nisbati|Stoke Corp - P/S multiplikatori|BLFS (BioLife) - Kapitalizatsiya va daromad nisbati|wavelifesciences.com (WVE) - Narxning daromadga nisbati|SION - Narx/daromad koeffitsiyenti|PRME (Prime Medicine Inc) - P/S multiplikatori|Taysha Gene Therapies, Inc. - Narxning sotuvga nisbati|P/S multiplikatori QURE|MGTX: Narxning sotuvga nisbati|Narxning daromadga nisbati REGENXBIO RGNX|SLDB: Kapitalizatsiya va daromad nisbati|OCGN: Kapitalizatsiyaning daromadga nisbati|PACB - P/S multiplikatori|BNTC (Benitec Corp) - Kapitalizatsiyaning daromadga nisbati|Narx/daromad multiplikatori Design Corp DSGN|Narxning daromadga nisbati Rocket Pharmaceuticals|P/S multiplikatori 4D Molecular Therapeutics, Inc.|Narxning daromadga nisbati Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EDIT (Editas Medicine, Inc.)|P/S multiplikatori Silence Therapeutics Corp SLN|PRQR - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Codexis Inc CDXS|SGMO: P/S multiplikatori|Kapitalizatsiya va daromad nisbati NAUT|Narxning daromadga nisbati metagenomi.co|P/S multiplikatori Precision BioSciences Inc.|P/S multiplikatori GBIO|Boundless Bio, Inc. - Kapitalizatsiya va daromad nisbati|P/S multiplikatori XCUR (Exicure, Inc.)|Narx/daromad koeffitsiyenti Imunon, Inc. (IMNN)|PHIO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati MBIO (mustangbio.com)|RNAZ: P/S multiplikatori|Kapitalizatsiya va daromad nisbati BNGO|APDN (Applied DNA Corp) - P/S multiplikatori|BLUE: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati ImmunoPrecise (IPA)|OMGA - Sotuvga nisbatan narx|Narxning daromadga nisbati Singular Genomics OMIC|Bozor kapitallashuvining daromadga nisbati RGLS|Syros Pharmaceuticals, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Telesis Bio Inc. TBIO|TRACON Pharmaceuticals, Inc. (TCON) - Narxning daromadga nisbati|Unity Biotechnology, Inc - Bozor kapitallashuvining daromadga nisbati